Myriad Genetics, Inc. (MYGN)
Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.
Recs
ttboydxb
(98.90)
Submitted: 11/20/2009 9:50:27 PM :
Start Price:
$24.27
MYGN Score:
-1.84
Betapeg pick, looks good...
Recs
jchoover
(90.64)
Submitted: 11/17/2009 3:21:22 PM :
Start Price:
$26.64
MYGN Score:
-12.39
portefeuille6
Recs
jasenj1
(83.26)
Submitted: 11/17/2009 6:54:09 AM :
Start Price:
$23.53
MYGN Score:
+1.45
Trying a biotech stock. Profitable, low P/E, has room to grow.
Recs
cougman
(< 20)
Submitted: 11/9/2009 9:01:18 PM :
Start Price:
$23.00
MYGN Score:
+2.32
This beaten down , bargain co. is a buy !
Recs
zzlangerhans
(99.52)
Submitted: 11/9/2009 5:59:54 PM :
Start Price:
$26.99
MYGN Score:
-32.07
Bought 1000 shares today at 22.6.
Recs
greatfoolsmiles
(30.73)
Submitted: 11/1/2009 4:07:27 AM :
Start Price:
$22.44
MYGN Score:
+4.48
MYGN has a great past record and expected to continue once the sector outlook improves. Buy at 52 week low
Recs
kenc132000
(89.98)
Submitted: 10/28/2009 9:52:43 AM :
Start Price:
$23.79
MYGN Score:
-4.55
New 52 week low. Blowout earnings last quarter. Strong support at $24 last several months.. Good growth prospects.
Recs
FitzColinGerald
(42.10)
Submitted: 10/27/2009 7:20:04 PM :
Start Price:
$24.63
MYGN Score:
-7.60
Myriad Genetics is a healthcare company that specializes in the development and marketing of prognostic medicine products. Such products include COLARIS and TheraGuide 5-FU, which measure a person's susceptibility to colon cancer and a person's response to 5-FU-based chemotherapy, respectively. These products are becoming increasingly important, as patients wish to assess their potential risks with certain diseases and treatments.
Recs
08PortfolioModel
(< 20)
Submitted: 10/9/2009 10:19:46 AM :
Start Price:
$25.09
MYGN Score:
-8.25
Current 25.11, Oct 9 09. Limit 25.11
Recs
MintCoin
(99.86)
Submitted: 9/28/2009 11:07:33 PM :
Start Price:
$27.21
MYGN Score:
-16.47
Didn't think this one would hit my price target. Hung in there though the worst of it but came back to earth when Obamacare lost steam. Above average fundamentals, technicals, and LT outlook. I think this one will easily beat the index regardless what happens in Washington.
Recs
libertybrewcity
(< 20)
Submitted: 9/15/2009 1:24:23 PM :
Start Price:
$30.40
MYGN Score:
-26.92
beautiful bio company
Recs
latimerburned
(78.93)
Submitted: 8/26/2009 12:55:43 PM :
Start Price:
$30.26
MYGN Score:
-29.48
Spun out their biopharma business to become a pure play in molecular diagnostics. Very good generator of FCF and sitting on mounds of cash. Growing at a pretty decent clip in a very Obamacare business. I like this one.
Recs
foy1
(< 20)
Submitted: 8/19/2009 10:09:48 AM :
Start Price:
$24.90
MYGN Score:
-16.73
sales growth, earnings growth,
retun on assets, retun on equity return on capital all over 25%
Recs
cougman68
(< 20)
Submitted: 8/17/2009 4:09:54 PM :
Start Price:
$24.94
MYGN Score:
-17.46
Simply RISK \ REWARD is just TOO great right now !
Recs
labmi
(< 20)
Submitted: 7/11/2009 12:10:31 PM :
Start Price:
$24.99
MYGN Score:
-30.79
steady increasing revenue
Recs
QwertyHero
(47.27)
Submitted: 7/2/2009 3:41:17 AM :
Start Price:
$26.12
MYGN Score:
-31.01
Huge selloff - it will go back up - will buy in real portfolio once im sure it's reached the bottom.
Recs
targetphil
(30.23)
Submitted: 7/1/2009 4:10:34 PM :
Start Price:
$26.12
MYGN Score:
-31.01
thought drop was just WAY TOO FAR! (from 35.46 to 26.02)
Recs
jcwenger
(< 20)
Submitted: 7/1/2009 9:09:51 AM :
Start Price:
$26.99
MYGN Score:
-32.07
Underpriced due to overreaction to revenue forecast miss
Recs
KingKev
(81.23)
Submitted: 6/19/2009 1:50:50 PM :
Start Price:
$37.01
MYGN Score:
-57.01
Fantastic company with several great products coming soon
Recs
kropopkin
(31.05)
Submitted: 6/11/2009 7:19:49 AM :
Start Price:
$36.82
MYGN Score:
-53.84
Unrealistic decline after last earnings, only because they weren't as huge as expected based on previous results. Great growth opportuity, and customised therapies are definitely the future of healthcare. MYGN is a good lower priced company for this, in the same vein as the sucessful CELG
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 71 1 2 3 4 Next »